ANI PHARMACEUTICALS INC — Director's Dealing 2014

Aug 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2014-08-20

Reporting Person: Schrepfer Robert W (VP Bus Dev & Con Mfg)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-20	Option to Purchase	$28.76	A	25000	Acquired	2024-08-19	Common Stock (25000)	Direct

Footnotes

F1: The options vest in an equal annual amount over a four-year period beginning on the first anniversary of the grant date.